FDA Coronavirus (COVID-19) Update: April 23rd, 2020
April 23, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen GmbH’s IntelliVue Patient Monitors MX750/MX850, IntelliVue 4-Slot Module Rack FMX-4 and IntelliVue Active Displays AD75/AD85, intended to be used by healthcare professionals in the hospital environment for remote monitoring of adult, pediatric and neonate patients having or suspected of having COVID-19 to reduce healthcare provider exposure.
Coronavirus
American Heart Association Urges Nation’s Pharmacies to Re-Think Selling Tobacco in Wake of New CDC Survey
September 4, 2016
Washington, D.C. – American Heart Association CEO Nancy Brown issued the following comments on new data from the Centers for Disease Control and Prevention published in the American Journal of Preventive Medicine.
The data came from Porter Novelli’s Summer Styles, a national survey that found 66 percent of adults 18 and over were strongly or somewhat in favor of banning the sale of all tobacco products in retail pharmacy stores:
Pharmacies urged to stop selling tobacco products.
Tennessee Board of Pharmacy Takes Action to Assure Safe, Sterile Drug Production
June 16, 2013
Nashville, TN – The Tennessee Board of Pharmacy has taken action to strengthen its efforts to better assure safe, sterile compounding of drugs by entities licensed by the state.
The measures collectively address the need for safe, effective and available medications for patients who need them. [Read more]
